Behavioral Therapy for Early Psychosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new behavioral therapy, called Adapted Behavioral Intervention, to help reduce violent behavior in individuals experiencing early psychosis. It targets those with conditions like schizophrenia or similar disorders who are already receiving treatment at specific clinics. Individuals diagnosed with early psychosis, experiencing symptoms like delusions or hallucinations for the first time, and seeking new coping strategies might be suitable candidates. Participants must be comfortable with interviews conducted in English throughout the study. As an unphased trial, this study provides a unique opportunity to explore innovative coping strategies for early psychosis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this behavioral intervention is safe?
Research shows that starting treatment early for psychosis is generally safe and can improve health. Studies have found that these treatments can help with symptoms and daily functioning over time. This trial uses a special type of therapy designed to help people manage early signs of psychosis and reduce violent behavior.
Although this study is still in the early stages and lacks detailed safety data, therapies like this are usually well-tolerated. Without medication, the risk of side effects is typically lower than with drug treatments. Previous research on similar early psychosis programs indicates they can be effective without causing significant harm.12345Why are researchers excited about this trial?
Researchers are excited about the adapted behavioral intervention for early psychosis because it offers a fresh approach to managing symptoms. Unlike traditional options like antipsychotic medications that often focus on chemical imbalances, this intervention targets emotional and cognitive responses, particularly anger, through psychological techniques. By tailoring the intervention to fit the OnTrackNY setting, there's hope that it will be more feasible and acceptable for both clinicians and participants, potentially leading to better outcomes for individuals experiencing early psychosis.
What evidence suggests that this behavioral intervention is effective for early psychosis?
Research has shown that certain treatments can help people with schizophrenia and similar disorders, often improving both medical and personal well-being. Early treatment of symptoms can reduce the likelihood of recurrence and enhance other outcomes. Specifically, treatments that include behavioral therapy can help manage symptoms and lower the risk of violent behavior. This trial will test the adapted behavioral intervention, which might help individuals with early psychosis manage their symptoms more effectively.23467
Who Is on the Research Team?
Paul S Appelbaum, MD
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for young adults aged 16 to 30 who are receiving treatment for early psychosis at OnTrackNY clinics and can participate in research interviews. They must have a diagnosis within the schizophrenia spectrum, excluding affective psychoses, and be fluent in English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week behavioral intervention to reduce violent behavior
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Adapted Behavioral Intervention
Adapted Behavioral Intervention is already approved in United States for the following indications:
- Early psychosis with violent behavior
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator